Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 4
2013 4
2014 7
2015 6
2016 9
2017 4
2018 2
2021 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-penetrating peptides.
Teesalu T, Sugahara KN, Ruoslahti E. Teesalu T, et al. Front Oncol. 2013 Aug 27;3:216. doi: 10.3389/fonc.2013.00216. eCollection 2013. Front Oncol. 2013. PMID: 23986882 Free PMC article.
Tumor-penetrating therapy for β5 integrin-rich pancreas cancer.
Hurtado de Mendoza T, Mose ES, Botta GP, Braun GB, Kotamraju VR, French RP, Suzuki K, Miyamura N, Teesalu T, Ruoslahti E, Lowy AM, Sugahara KN. Hurtado de Mendoza T, et al. Nat Commun. 2021 Mar 9;12(1):1541. doi: 10.1038/s41467-021-21858-1. Nat Commun. 2021. PMID: 33750829 Free PMC article.
Tumor penetrating peptides for improved drug delivery.
Ruoslahti E. Ruoslahti E. Adv Drug Deliv Rev. 2017 Feb;110-111:3-12. doi: 10.1016/j.addr.2016.03.008. Epub 2016 Apr 1. Adv Drug Deliv Rev. 2017. PMID: 27040947 Free PMC article. Review.
Mapping of vascular ZIP codes by phage display.
Teesalu T, Sugahara KN, Ruoslahti E. Teesalu T, et al. Methods Enzymol. 2012;503:35-56. doi: 10.1016/B978-0-12-396962-0.00002-1. Methods Enzymol. 2012. PMID: 22230564 Review.
Tumor-penetrating iRGD peptide inhibits metastasis.
Sugahara KN, Braun GB, de Mendoza TH, Kotamraju VR, French RP, Lowy AM, Teesalu T, Ruoslahti E. Sugahara KN, et al. Mol Cancer Ther. 2015 Jan;14(1):120-8. doi: 10.1158/1535-7163.MCT-14-0366. Epub 2014 Nov 12. Mol Cancer Ther. 2015. PMID: 25392370 Free PMC article.
New p32/gC1qR Ligands for Targeted Tumor Drug Delivery.
Paasonen L, Sharma S, Braun GB, Kotamraju VR, Chung TD, She ZG, Sugahara KN, Yliperttula M, Wu B, Pellecchia M, Ruoslahti E, Teesalu T. Paasonen L, et al. Chembiochem. 2016 Apr 1;17(7):570-5. doi: 10.1002/cbic.201500564. Epub 2016 Feb 19. Chembiochem. 2016. PMID: 26895508 Free PMC article.
Gated Luminescence Imaging of Silicon Nanoparticles.
Joo J, Liu X, Kotamraju VR, Ruoslahti E, Nam Y, Sailor MJ. Joo J, et al. ACS Nano. 2015 Jun 23;9(6):6233-41. doi: 10.1021/acsnano.5b01594. Epub 2015 Jun 9. ACS Nano. 2015. PMID: 26034817 Free PMC article.
32 results